Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-24

FDA Approved: GLYCEROL PHENYLBUTYRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for glycerol phenylbutyrate, a drug used to treat urea cycle disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycerol phenylbutyrate (glycerol phenylbutyrate)

Snippet

SUPPL AP for GLYCEROL PHENYLBUTYRATE (GLYCEROL PHENYLBUTYRATE)